Can aspirin prevent colorectal cancer?

Lancet

Volumn 369, Issue 9573, 2007, Pages 1577-1578

  Chan, Andrew T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; COLORECTAL CANCER; DIAGNOSTIC IMAGING; DRUG DOSE COMPARISON; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; LABORATORY TEST; LONG TERM CARE; PREVENTION AND CONTROL; PRIORITY JOURNAL; SCREENING TEST;

EID: 34248231930     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60720-X     Document Type: Note

References (14)

1. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
2. Thun M., Henley S., and Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94 (2002) 252-266
3. Baron J., Cole B., Sandler R., et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348 (2003) 891-899
4. Sandler R., Halabi S., Baron J., et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348 (2003) 883-890
5. Benamouzig R., Deyra J., Martin A., et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125 (2003) 328-336
6. Gann P., Manson J., Glynn R., Buring J., and Hennekens C. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85 (1993) 1220-1224
7. Sturmer T., Glynn R., Lee I., Manson J., Buring J., and Hennekens C. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med 128 (1998) 713-720
8. Cook N., Lee I., Gaziano J., et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294 (2005) 47-55
9. Flossmann E., Rothwell P., and on behalf of the British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369 (2007) 1603-1613
10. Chan A., Giovannucci E., Meyerhardt J., Schernhammer E., Curhan G., and Fuchs C. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294 (2005) 914-923
11. Larsson S., Giovannucci E., and Wolk A. Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer 95 (2006) 1277-1279
12. Jacobs E., Thun M., Bain E., Rodriguez C., Henley S., and Calle E. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99 (2007) 608-615
13. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
14. Dube C., Rostom A., Lewin G., et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146 (2007) 365-375